ArticleCancer medicine2026

Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor.

Mallikarjuna Nimgampalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.